Cargando…
Development of tumor lysis syndrome (TLS): A potential risk factor in cancer patients receiving anticancer therapy
Tumor lysis syndrome (TLS) is characterized by hyperuricaemia, hyperphosphatemia, hyperkalaemia, as well as hypocalcaemia due to the breakdown of tumor cells undergoing cancer therapy (chemo/radio). Therefore it is of interest to evaluate oxidative stress using selective biological markers [Malondia...
Autores principales: | Rasool, Mahmood, Malik, Arif, Qureshi, Muhammad Saeed, Ahmad, Riaz, Manan, Abdul, Asif, Muhammad, Naseer, Muhammad Imran, Pushparaj, Peter Natesan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Biomedical Informatics
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261116/ https://www.ncbi.nlm.nih.gov/pubmed/25512688 http://dx.doi.org/10.6026/97320630010703 |
Ejemplares similares
-
Implications of prognostic variables in the assessment of autoimmunity in hepatitis C patients receiving interferon therapy
por: Arooj, Mahwish, et al.
Publicado: (2016) -
Recent Updates in the Treatment of Neurodegenerative Disorders Using Natural Compounds
por: Rasool, Mahmood, et al.
Publicado: (2014) -
Comparative Study of Alterations in Tri-iodothyronine (T3) and Thyroxine (T4) Hormone Levels in Breast and Ovarian Cancer
por: Rasool, Mahmood, et al.
Publicado: (2014) -
Role of the antineoplastic drug bleomycin based on toxicogenomic-DNA damage inducing (TGx-DDI) genomic biomarkers data: A meta-analysis
por: Pushparaj, Peter Natesan, et al.
Publicado: (2023) -
Exploration of potential molecular mechanisms and genotoxicity of anti-cancer drugs using next generation knowledge discovery methods
por: Pushparaj, Peter Natesan, et al.
Publicado: (2023)